Melanotan 1
Cosmeticα-MSH analog / research listingExperimental
Same peptide as FDA-approved afamelanotide (SCENESSE). Research-chem “Melanotan I” vials are not the approved implant and are not a legal tanning drug.
For research use only.
Key Facts
- CAS
- 75921-69-6
- Molecular Weight (MW)
- 1646.85 g/mol
- Half-life
- ~30 minutes
- Unit
- mcg
- Administration Route
- Subcutaneous
- Frequency
- Daily/every other day
- Last updated
- 8/23/2026
- Targets
- MC1R
Overview
Same peptide as FDA-approved afamelanotide (SCENESSE). Research-chem “Melanotan I” vials are not the approved implant and are not a legal tanning drug.
Protocol
- Dosage Range
- 250 mcg-1.5 mg daily
- Frequency
- Daily/every other day
- Cycle
- Until tan achieved, then maintenance
- Administration Route
- Subcutaneous
- Reconstitution Guide
- 3 mL BAC for 10 mg vial
Science
Mechanism of Action
MC1R agonist that increases eumelanin. The approved product is a controlled-release implant for EPP, not a compounding tanning vial.
Targets
MC1R
Studies
- Afamelanotide EPP— Journal/year not available
Benefits
Same pharmacology as afamelanotide
Potential Side Effects
- Nausea
- Flushing
- Hyperpigmentation
References
- FDA SCENESSE labelExternal link · Year —